ANN ARBOR -- The medical device startup Everist Genomics Wednesday announced plans to commercialize its CardioDefender diagnostic system. CardioDefender is the first FDA-approved and CE ...
ANN ARBOR, Mich., Nov. 9, 2011 /PRNewswire/ — Everist Genomics, a rapidly growing personalized medicine company developing and commercializing innovative diagnostics and prognostics, today announced ...
German airline Lufthansa has recently started using a mobile ECG system with telemedical support on all long-haul flights. The new system is intended to ensure safer travel for passengers on board in ...
Personal MedSystems introduces the first and only 22-lead mobile ECG system, CardioSecur, at the European Society of Cardiology Congress 2015. The next generation of ECG solutions can be run with a ...
New York, Jan. 10, 2023 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Mobile ECG Devices Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Modality, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results